This inventor holds 2 USPTO granted patents. Top assignee: The Dupont Merck Pharmaceutical Company. Active years: 1993-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1995
Title: The Innovative Contributions of Leon De Brabander, Jr.
Introduction: Leon De Brabander, Jr., based in Wilmington, Delaware, is a notable inventor recognized for his significant contributions to cognitive enhancing compounds. With two patents to his name, his work has positioned him as a key player in the field of pharmaceutical innovation.
Latest Patents: Leon's latest inventions include groundbreaking patents focused on disubstituted polycyclic systems. These patents, described as polycyclic cognition enhancers, feature a general formula where R1 is a heterocyclic aromatic moiety such as a 4-pyridyl, 2-pyridyl, 4-pyrimidyl, or pyrazinyl group. These innovations promise advancements in cognitive enhancement, showcasing the application of chemical structures in improving mental functions.
Career Highlights: Leon De Brabander, Jr. is associated with the DuPont Merck Pharmaceutical Company, where he has devoted his expertise to the development of advanced pharmaceutical solutions. His work emphasizes the potential of polycyclic systems in therapeutic contexts, underlining his commitment to enhancing human cognitive capabilities through innovation.
Collaborations: Throughout his career, Leon has collaborated with esteemed colleagues such as James H. Jensen and Timothy D. Costello. These partnerships have facilitated a dynamic exchange of ideas and expertise, contributing to the overall success of their innovative projects within the pharmaceutical industry.
Conclusion: Leon De Brabander, Jr. stands out as a prominent inventor whose patents reflect a deep understanding of chemical compositions aimed at cognitive enhancement. His contributions through DuPont Merck Pharmaceutical Company, alongside notable collaborators, continue to influence advancements in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile